Last reviewed · How we verify

NCT05379465

The Impact of the COVID-19 Pandemic on the Career Choice of Medicine

Completed Last updated 18 May 2022
What this trial tests

trial testing No intervention in Career Choice of Medicine in 1,695 participants. Completed in 14 November 2020.

Timeline
16 October 2020
Primary endpoint
14 November 2020
14 November 2020

Quick facts

Lead sponsorAga Khan University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,695
Start date16 October 2020
Primary completion14 November 2020
Estimated completion14 November 2020
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Aga Khan University

Who can join

Adults 14 to 20, any sex, with Career Choice of Medicine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to determine what impact the COVID-19 pandemic may have had on the choices of high school students to pursue medicine as a career.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The impact of the COVID-19 pandemic on the career choice of medicine: A cross-sectional study amongst pre-medical students in Pakistan.
    Saleh R, Martins RS, Saad M, Fatimi AS, et al · · 2022 · cited 2× · PMID 35957649 · DOI 10.1016/j.amsu.2022.104219

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other Aga Khan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05379465.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing